Semax 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview Semax is a heptapeptide research compound studied for its relevance to neurotrophic signalling, cognitive-pathway modelling and biochemical response behaviour within CNS-related research. This lyophilized 10 mg peptide supports controlled laboratory evaluation of purity identity and mechanistic neuropeptide activity.   Peptide Overview Between 2010 and 2025 Semax gained increasing scientific attention due to its involvement in neurochemical modulation, potential neuroprotective-pathway signalling and receptor-linked biochemical patterns. Its structural stability and reproducible analytical profile support consistent in-vitro neuropeptide research.   Historical Background and Scientific Context Research into neuroactive peptides expanded significantly from 2012 onward as laboratories evaluated their potential influence on central-nervous-system signalling. Semax became widely used in mechanistic modelling studies due to its predictable behaviour, high purity and reliable analytical identity.   Mechanistic Focus in Research

• Neuropeptide-signalling and CNS-pathway modelling
• Cognitive-modulation and biochemical response evaluation
• Comparative analysis with related neuroactive peptides
• Biochemical pathway-regulation studies
• Controlled in-vitro structure–function modelling

  Analytical Verification (COA) Independent Liquilabs analysis confirms full analytical validation for Batch GF092025040. Key results include:

• Assay Content: 10.90 mg
• Identification – Retention Time: 0.999
• Identification – Spectrum: 997
• Purity: above 99.8 percent
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count yeast or mold
• Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury vanadium

Values were produced using validated chromatographic spectroscopic and microbiological methodologies ensuring transparent documentation and full traceability.   Research Applications

• Cognitive-pathway biochemical modelling
• Neuropeptide-signalling research
• Mechanistic CNS-pathway and receptor-response evaluation
• Comparative neuroactive-peptide analysis
• Controlled in-vitro CNS-modelling experiments

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF092025040 – Published October 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.